According to the World Health Organization, the fluoride content in drinking water should be < 1.5 mg/L. A safe amount of fluoride not only prevents caries, it also affects bone metabolism, hematopoietic function, growth, the immune system, and the nervous system [18]. However, a safe range of fluoride in the human body is narrower than that of other trace elements, and excessive intake can cause fluorosis.
Fluorosis can cause: (i) memory loss; (ii) behavioral manifestations of nervous-system damage (e.g., decreased IQ and cognitive dysfunction) in children [19]. The mechanisms of damage to the nervous system caused by fluorosis are not clear. Previously, we found that the mechanism of cognitive impairment induced by fluorosis was apoptosis and oxidative damage of neurons in the hippocampus [20]. We also found that 2-BFI application could improve cognitive impairment by inhibiting neuron apoptosis and protecting mitochondrial function in AD rats [11]. Some reports have suggested that dysfunctional ERMCS is a cause of apoptosis, emergency oxidative responses, and neuroinflammation [21]. Therefore, we suspect that the nerve damage caused by fluorosis is related to dysfunctional EMRCS.
We explored the relationship between dysfunctional EMRCS and nerve damage induced by fluoride, and investigated the protective effects of 2-BFI on SH-SY5Y cells treated with fluoride.
NaF (0–4 mmol/L) was used to treat SH-SY5Y cells for 24 h, and cell viability was evaluated by the CCK-8 assay and apoptosis was detected by Annexin PI/FITC staining. The cytotoxic effect of fluoride increased with increasing concentrations of NaF (Fig. 1), and NaF at 2 mmol/L was used for subsequent experiments.
Several studies have shown that the 12R is present widely in the central nervous system (CNS), can participate in regulation of various brain functions, and is related to the occurrence of several diseases [22]. 2-BFI is a selective and high-affinity 12R agonist first reported by Lione and colleagues in 1996 [23]. Previously, we showed that 2-BFI can alleviate oxidative stress, inhibit mitochondrial apoptosis, and improve cognitive impairment in AD rats [11]. However, whether 2-BFI can improve the nerve damage induced by fluoride has not been reported.
We used 2-BFI (2.5, 5, 10, 25, 50 µmol/L) to treat SH-SY5Y cells pretreated with NaF (2 mmol/L) for 24 h. If the 2-BFI concentration was too low or too high, it had a toxic effect on SH-SY5Y cells (Fig. 2). However, we also found that 2-BIF at 10 µmol/L could significantly increase the viability and decrease percent apoptosis of SH-SY5Y cells exposed to NaF compared with that in the NaF group. This result suggested that 2-BFI could alleviate fluoride-induced nerve damage and inhibit apoptosis.
Neuroinflammation seems to be an important mediator of the effects of fluoride [6]. Neuroinflammation contributes to most pathologic neurologic processes, including CNS infections, ischemic stroke, neurodegenerative disease, and anesthesia-induced neurotoxicity [24, 25]. Neuroinflammation is characterized by ROS release, Ca2+ overload, and MMP changes [13]. ERs and mitochondria are closely connected through EMRCS. Dysfunctional ERMCS can cause mitochondrial Ca2+ overload [14]. Therefore, we investigated the basic composition of EMRCS in SH-SY5Y cells exposed to NaF.
ERMCS are dynamic structures that connect ERs and mitochondria. They are composed of Ca2+ channels (IP3R) located on the ER or the outer mitochondrial membrane, VDAC, various molecular chaperone proteins (e.g., GPR75), enzymes associated with lipid biosynthetic pathways, lipid-transfer proteins, calnexin, and sigma-1 receptors [14]. Protein and mRNA expression of IP3R, GRP75, and VDAC were significantly higher in the NaF group than those in the control group (Fig. 3, Fig. 4). 2-BFI could effectively reduce protein and mRNA expression of IP3R, GRP75, and VDAC compared with that in the NaF group. These results indicated that 2-BFI could maintain the structural stability of EMRCS. A stable EMRCS structure could have a neuroprotective effect against fluorosis, which is reflected by reducing ROS release, alleviating Ca2+ overload, and regulating the MMP (Fig. 5).
In recent years, some scholars have discovered that mitochondrial Ca2+ overload can produce excessive ROS, which causes activation of many NLRP3 inflammasomes and promotes release of proinflammatory factors [26]. In the inactive state, NLRP3 is located mainly on the ER membrane and cytoplasm. However, in the activated state, NLRP3 and apoptosis-related punctate proteins relocate to ERMCS to form NLRP3 inflammasomes to promote the release of ROS that damage mitochondria [27, 28]. The NLRP3 inflammasome (which is composed of NLRP3 and ASC-1) can trigger caspase-1 activation, promote the secretion of IL-6 and IL-1β, and induce neuronal apoptosis [16]. We found that NaF could increase expression of NLRP3 and ASC-1 and caspase-1 (Fig. 6A–D). Activated NLRP3 inflammasomes further promoted IL-1β release (Fig. 6E). However, 2-BFI could inhibit activation of NLRP3 inflammasomes and the initiation of neuroinflammation and apoptosis, and reduce the release of proinflammatory factors.